Skip to content

Comparison of different weight-based scalars of ciprofol for anesthesia induction in obese patients

Comparison of different weight-based scalars of ciprofol for anesthesia induction in obese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114374
Enrollment
Unknown
Registered
2025-12-11
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia for obese patients

Interventions

Total body weight(TBW) Group:During anesthesia induction, ciprofol was administered via infusion pump based on the patients' total body weight (TBW).
Lean body weight(LBW) Group:During anesthesia induction, ciprofol was administered via infusion pump based on the patients' lean body weight (LBW).
Corrected body weight(CBW) Group:During anesthesia induction, ciprofol was administered via infusion pump based on the patients' corrected body weight (CBW).
Control Group:During anesthesia induction, ciprofol was administered via infusion pump based on the patients' total body weight (TBW).

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years. 2. Assigned to one of two groups based on Body Mass Index (BMI):Experimental Group:** BMI >= 30.0 kg/m^2. Control Group:** BMI >= 18.5 kg/m^2 and < 25.0 kg/m^2. 3. American Society of Anesthesiologists (ASA) physical status II or III.

Exclusion criteria

Exclusion criteria: 1. Significant cardiopulmonary comorbidities; 2. Severe hepatic or renal impairment; 3. Hypersensitivity to ciprofol or its components; 4. Long-term use of benzodiazepines; 5. Predicted difficult airway; 6. Pre-existing psychiatric conditions impairing cooperation; 7. History of chronic alcohol abuse; 8. Diagnosis of myasthenia gravis.

Design outcomes

Primary

MeasureTime frame
Ciprofol Dosage;

Secondary

MeasureTime frame
Time to loss of consciousness (LOC), defined as MOAA/S <= 1;Hemodynamics;Injection pain;Respiratory depression;

Countries

China

Contacts

Public ContactFaping Tu

Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College

tfpnc@163.com+86 138 0827 0833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026